The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Advancing genome-based precision medicine: a review on machine learning applications for rare genetic disorders
Open accessAbstract
Precision medicine tailors medical procedures to individual genetic overviews and offers transformative solutions for rare genetic conditions. Machine learning (ML) has enhanced genome-based precision medicine (GBPM) by enabling accurate diagnoses, customized treatments, and risk assessments. ML tools, including deep learning and ensemble methods, process high-dimensional genomic data and reveal discoveries in rare diseases. This review analyzes the ML applications in GBPM, emphasizing its role in disease classification, therapeutic optimization, and biomarker discovery. Key challenges, such as computational complexity, data scarcity, and ethical concerns, are discussed alongside advancements such as hybrid ML models and real-time genomic analysis. Security issues, including data breaches and ethical challenges, are addressed. This review identifies future directions, emphasizing the need for comprehensible ML models, increasing data-sharing frameworks, and global collaborations. By integrating the current research, this study provides a comprehensive perspective on the use of ML for rare genetic disorders, paving the way for transformative advancements in precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Artificial intelligence and machine learning in precision and genomic medicine
Quazi, S. (2022) · Medical Oncology · doi:10.1007/s12032-022-01711-1 · Cited by 432
RetractedInterpreting Black-Box Models: A Review on Explainable Artificial Intelligence
Hassija, V., Chamola, V., Mahapatra, A., Singal, A., Goel, D., Huang, K., Scardapane, S., Spinelli, I., Mahmud, M., & Hussain, A. (2024) · Cognitive Computation · doi:10.1007/s12559-023-10179-8 · Cited by 2,495 · cited 2×
“Future frameworks should adopt dynamic consent models allowing participants to update their preferences when new research applications emerge [136].”
A universal SNP and small-indel variant caller using deep neural networks
Poplin, R., Chang, P.-C., Alexander, D., Schwartz, S., Colthurst, T., Ku, A., Newburger, D., Dijamco, J., Nguyen, N., Afshar, P. T., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4235 · Cited by 1,840 · cited 1×
“These advancements are particularly beneficial for diagnosing rare genetic conditions for which conventional methods may fall short [99].”
Ji, Y., Zhou, Z., Liu, H., & Davuluri, R. V. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab083 · Cited by 1,303
Privacy and artificial intelligence: challenges for protecting health information in a new era
Murdoch, B. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00687-3 · Cited by 991 · cited 1×
“Furthermore,algorithmicbiascanleadtodisparitiesinhealthcare outcomes, underscoring the need for fair and transparent model development [31–33].”
Nucleotide Transformer: building and evaluating robust foundation models for human genomics
Dalla-Torre, H., Gonzalez, L., Mendoza-Revilla, J., Lopez Carranza, N., Grzywaczewski, A. H., Oteri, F., Dallago, C., Trop, E., de Almeida, B. P., Sirelkhatim, H., et al. (2025) · Nature Methods · doi:10.1038/s41592-024-02523-z · Cited by 772 · cited 1×
“This gap presents a fertile Emerging models like the Nucleotide Transformer,which scales to billions of parameters and has been pretrained on massive nucleotide datasets,demonstrate the feasibility of adapting lar ge-scale transformer architectures for biological applications [110].”
The Nucleotide Transformer: Building and Evaluating Robust Foundation Models for Human Genomics
Lopez, M., Dalla-Torre, H., Gonzalez, L., Mendoza-Revilla, J., Carranza, N. L., Grzywaczewski, A., Oteri, F., Dallago, C., Trop, E., Sirelkhatim, H., et al. (2023) · doi:10.21203/rs.3.rs-2644486/v1 · Cited by 680
The Nucleotide Transformer: Building and Evaluating Robust Foundation Models for Human Genomics
Dalla-Torre, H., Gonzalez, L., Mendoza Revilla, J., Lopez Carranza, N., Henryk Grywaczewski, A., Oteri, F., Dallago, C., Trop, E., De Almeida, B. P., Sirelkhatim, H., et al. (2023) · doi:10.1101/2023.01.11.523679 · Cited by 680
From big data analysis to personalized medicine for all: challenges and opportunities
Alyass, A., Turcotte, M., & Meyre, D. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0108-y · Cited by 557
Explainable AI for Healthcare 5.0: Opportunities and Challenges
Saraswat, D., Bhattacharya, P., Verma, A., Prasad, V. K., Tanwar, S., Sharma, G., Bokoro, P. N., & Sharma, R. (2022) · IEEE Access · doi:10.1109/access.2022.3197671 · Cited by 523
Research works printed but not linked: 22
- Global Cybersecurity Network, 2024, Cyber security of genomic data
- Mitta, 2023, Machine learning for personalized medicine: tailoring treatment strategies based on individual patient data, Hong Kong J AI Med, 3, 49
- Ogunsakin, Leveraging ai for healthcare administration: streamlining operations and reducing costs, IRE Journals, 7
- Nadella, 2023, A systematic literature review of advancements, challenges and future directions of ai and ML in healthcare, Int J Mach Learn Sustain Dev, 5, 115
- CRISPR Medicine News, 2024, OpenCRISPR-1: Generative AI Meets CRISPR
- SciTech Daily, 2024, Creme: A New Ai-Powered Virtual Lab to Help Cure Genetic Diseases
- Australian, 2024, Rare Diseases Receive Huge Genomics Boost
- Deshmukh, 2024, Reinforcement learning in healthcare: applications for personalized treatment planning and clinical decision support, Shodh Sagar J Artif Intell Mach Learn, 1, 19
- Trust, 2024, Data and Diversity in Genomics: A Global Landscaping Report
- Wellcome Trust, 2024, Data and Diversity in Genomics: Landscaping Report
- Yaghi, 2024, Genetic Data in Jeopardy: Unraveling the Details of the Aftermath of 23andMe Hack
- Blum, 2024, When Hospital Ransomware Attacks Threaten Patient Safety: A New Trend to Follow
- Compagnucci, 2024, A multidisciplinary perspective on cross-border health data transfers, Forthcoming
- Pulivarti, 2023, Cybersecurity of genomic data
- Borfitz, 2024, AI System for Diagnosing Rare Diseases and Solving Medical Cold Cases
- National Human Genome Research Institute, 2021, Nhgri machine learning in genomics workshop: tools, resources, clinical applications, and ethics, Exec Sum
- Whole-genome alignment, 2023, Methods, challenges, and future directions. MDPI, Appl Sci, 14, 4837
- Tutorials, 2023, Mining Massive Biological Datasets for New Discoveries with Scalable Algorithms
- Joly, 2023, The GA4GH regulatory and ethics work stream (rews) at 10: An interdisciplinary, participative approach to international policy development in genomics, 13
- Precision Medicine, 2024, AI-driven precision medicine gains momentum in 2024. Precision medicine, Online
- The Australian, 2024, Magic Medicine? The Revolution in Genes and Health
- The Atlantic, 2024, The most Important Breakthroughs of 2024
Cited by
Abbas, Q., Jeong, W., & Lee, S. W. (2025) · Healthcare · doi:10.3390/healthcare13172154 · Cited by 236
“Explainable AI offers a promising approach to translating complex computational decisions into human-understandable forms, ultimately enhancing both diagnostic confidence and patient safety [33,44].”
Self-citation
Metadata
- Authors
- Abbas, S. R., Abbas, Z., Zahir, A., & Lee, S. W.
- Affiliations
- Sungkyunkwan University (KR)
- Incheon National University (KR)
- Kangbuk Samsung Hospital (KR)
- Corresponding author
- Lee, Seung Won
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2025-07
- Volume
- 26
- Issue
- 4
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- PMC
- PMC12265892
- OpenAlex
- W4412487264
- Semantic Scholar
- a6cedaf514c21b46313ada7645475c342350e27f
- Cited by
- 30
- References
- 133
- Citations by year
- 2026: 20 · 2025: 10
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Briefings in Bioinformatics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Keywords
- rare genetic disorders, machine learning, deep learning, ensemble methods, disease classification, treatment optimization, biomarker discovery, genomic data security, data breaches, explainable machine learning, genomic data sharing, ethical considerations
- MeSH terms
- Machine Learning, Humans, Genome, Human, Genomics, Genetic Diseases, Inborn, Rare Diseases, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advancing genome-based precision medicine: a review on machine learning applications for rare genetic disorders. https://app.cochat.ai/papers/10.1093/bib/bbaf329
- The paper
- Abbas, S. R., Abbas, Z., Zahir, A., & Lee, S. W. (2025). Advancing genome-based precision medicine: a review on machine learning applications for rare genetic disorders. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf329
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.